Hazardous Materials. Client warrants to [[CoreRx:Organization]] that no specific safe handling instructions are applicable to any Client-supplied materials, except as disclosed to [[CoreRx:Organization]] in writing by the Client in sufficient time for review and training by [[CoreRx:Organization]] prior to delivery. Client will provide safety and potency ratings for the active pharmaceutical ingredients (API) and [[CoreRx:Organization]] assumes the materials have been assigned a level ​ (or lower) SafeBridge or equivalent safety rating. Rating shall be provided by SafeBridge or an equivalent certified consultant. [[CoreRx:Organization]] assumes no liability for Client’s compound(s).

Other Materials. On each date on which the Company is required to deliver a certificate pursuant to Section 7(l), the Company shall have furnished to the Agent such appropriate further information, certificates and documents as the Agent may reasonably request. All such opinions, certificates, letters and other documents will be in compliance with the provisions hereof. The Company will furnish the Agent with such conformed copies of such opinions, certificates, letters and other documents as the Agent shall reasonably request.

Raw Materials. All Raw Materials shall be procured by Alba in accordance with applicable laws and regulations. Alba shall be responsible for the quality of the Raw Materials used in the manufacture of Products and for their conformity with the Exclusive Product Specifications or the Non-Exclusive Product Specifications, whichever are applicable.

Biological Materials. Arcturus may from time to time provide to Providence samples of Collaboration Compounds (“Arcturus Materials”). Except as otherwise provided under this Agreement, such transfer shall convey no rights in such Arcturus Materials. All such Arcturus Materials delivered shall remain the sole property of Arcturus. Except as otherwise authorized under this Agreement, such Arcturus Materials shall not be used for any purpose other than the commercialization of the applicable Collaboration Tumor Type, and shall not be used by, delivered to or used for the benefit of, any Third Party (other than its subcontractors pursuant to Section 4.1) without the prior written consent of Arcturus, and shall not be used in research or testing involving human subjects. Because not all of their characteristics may be known, the Arcturus Materials supplied under this [Section 3.8] must be used with prudence and appropriate caution in any experimental work. THE ARCTURUS MATERIALS ARE PROVIDED “AS IS” AND WITHOUT ANY REPRESENTATION OR WARRANTY, EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTY OF DESIGN, MERCHANTABILITY, MERCHANTABLE QUALITY, DURABILITY, FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF THE INTELLECTUAL PROPERTY RIGHTS OF THIRD PARTIES.

Biological Materials. In order to facilitate the Development activities by the Parties pursuant to this Agreement, and the Development and Commercialization of Collaboration Compounds and Products in the Licensed Field by Providence under this Agreement, each of the Parties may from time to time provide to the other biological or other materials owned by or licensed to a Party (“Biological Materials”). Except as otherwise provided under this Agreement, such transfer shall convey no rights in such Biological Materials, except for the Development activities by the Parties pursuant to this Agreement, and the Development and Commercialization of Collaboration Compounds and Products in the Licensed Field by Providence under this Agreement. All such Biological Materials delivered shall remain the sole property of the delivering Party. Except as otherwise authorized under this Agreement, such Biological Materials shall not be used for any purpose other than the Development activities by the Parties pursuant to this Agreement, and the Development and Commercialization of Collaboration Compounds and Products in the Licensed Field by Providence under this Agreement, as the case may be, and shall not be used by, delivered to or used for the benefit of, any Third Party (excluding any Sublicensee or subcontractor (including contract research organizations and contract manufacturing organizations) relating to the Development and Commercialization of the Collaboration Compound or Product) without the prior written consent of the delivering Party, and shall not be used in research or testing involving human subjects. Because not all of their characteristics may be known, the Biological Materials supplied under this [Section 5.4] must be used with prudence and appropriate caution in any experimental work. THE BIOLOGICAL MATERIALS ARE PROVIDED “AS IS” AND WITHOUT ANY REPRESENTATION OR WARRANTY, EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTY OF DESIGN, MERCHANTABILITY, MERCHANTABLE QUALITY, DURABILITY, FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF THE INTELLECTUAL PROPERTY RIGHTS OF THIRD PARTIES.

#[[Organization A:Organization]] shall provide all Raw Materials for use at the Property to make the Commercial Product. [[Organization A:Organization]] shall be the owner of the Raw Materials, all intermediate materials, and the Commercial Product made therefrom.

Hazardous Materials. With the exception of office and cleaning supplies typically used for the permitted uses of the Premises, Tenant shall not store any Hazardous Materials as identified in 22 California Code of Regulations Sections 66261.1 et seq., as they may be amended from time to time at the Premises or Common Areas thereto.

Delivery. Landlord’s failure to Substantially Complete the Landlord’s First Floor Expansion Premises TI Work on or before the anticipated date of Substantial Completion, as set forth in Attachment 2, or to substantially complete any element of the Landlord’s First Floor Expansion Premises TI Work, shall not give rise to any liability of Landlord hereunder, shall not constitute a default by Landlord, and shall not affect the validity of this Amendment.

Delivery. All Product shall be delivered ​ (as defined by Incoterms® 2010). [[Lonza:Organization]] shall deliver to Customer the Certificate of Analysis and such other documentation as is reasonably required to meet all applicable regulatory requirements of the Governmental Authorities not later than the date of delivery of Batches (the “Release”). With respect to any Customer Materials, title and risk of loss shall remain with the Customer and shall not transfer to [[Lonza:Organization]]. With respect to Product, title and risk of loss shall remain with [[Lonza:Organization]] until Release, and shall transfer to Customer upon Release in accordance with this provision.

Delivery. Company has delivered, or caused to be delivered, to each Agent and each Lender complete and correct copies of # each Related Agreement and of all exhibits and schedules thereto as of the Original Closing Date, and # copies of any material amendment, restatement, supplement or other modification to or waiver of each Related Agreement entered into after the Original Closing Date.